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Purpose. To examine causes as well as extent of delay in diagnosis and treatment of primary open angle glaucoma patients in a
sample of Egyptians. Patients and Methods. 440 patients with primary open angle glaucoma were interviewed to evaluate delay in
their diagnosis and treatment. The extent and cause of delay were investigated. The total delay interval, if any, was correlated with
socioeconomic and other factors. Results. Themedian total delay was one year, with 50% of patients having a total delay of 1 year or
less, of which 25% exhibited zero total delay. 25% of patients had a delay ranging from 1 to 3 years, and 25% had a total delay ranging
from 3 to 27 years. Diagnostic delay accounted for 43.03% of cases. Longer delays were met in patients with certain socioeconomic
factors. Patients with a positive family history of glaucoma displayed shorter delay periods. Conclusion. Significant delay in the
diagnosis and treatment of glaucoma was found. Poor socioeconomic status seems to hinder timely diagnosis and treatment of
POAG. Certain socioeconomic factors seem to correlate with the extent of delay. More effort is thus needed to subsidize the cost of
investigations and treatment for glaucoma patients.
1. Introduction
The magnitude of glaucoma as a potentially blinding disease
is continually under study. The risk of blindness from treated
primary open angle glaucoma (POAG) over a period of 12–
20 years is estimated to range from 14.5% to 27% in unilateral
cases and from 7 to 9% in bilateral cases [1].These figuresmay
slightly differ in developing countries like Egypt. However,
the timing of diagnosis and management of glaucoma are
of crucial importance to the prognosis of the disease and its
effect on the patient’s lifestyle. Earlier treatment of patients
will alter their mode of progression and thus may delay or
totally prevent patients from reaching the stage of visual
disability during their lifetime [2]. A patient with visual
disability may have to resign from his job, stop driving,
and/or become more dependent. Visual disability is likely
once the patient reaches scale 8 on the disc damage likelihood
scale (DDLS) [3].
A large percentage of glaucoma patients reside in devel-
oping countries where there are special challenges. The low
socioeconomic status ofmost patients and the lack of facilities
and scarcity of glaucoma specialists, well equipped glaucoma
clinics, and screening programs may all contribute to the
difficulty of timely detection of disease [4, 5].
In our glaucoma practice, we noted that a lot of patients
exhibit a well established to advanced optic disc damage
(DDLS 5–10) at first presentation. These patients suffered
from restrictions in some of their life activities. Some patients
had to change or resign from a certain job. Others stopped
driving or felt dependent on other people.The authors did not
find enough studies on the problem of delay in diagnosis and
management of open angle glaucoma in Egypt or the Middle
East [5]. This compelled the authors to conduct a study to
further evaluate the causes and extent of this delay, if any.
The authors, however, found a few studies addressing the
delay in diagnosis and management of other diseases like
pulmonary tuberculosis in developing countries like India
and Ethiopia [6, 7].
In this cross-sectional survey study, we interviewed a
sample of 440 Egyptian patients, all previously diagnosed
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with primary open angle glaucoma (POAG) [8] with the
aim of understanding the extent and causes of delay (if
any) in their diagnosis and management. We also looked at
the correlation between the extent of this delay and other
demographic as well as socioeconomic factors. We asked the
patients about restrictions in their life activities, for example,
if they ever had to change or resign from a job or stop driving
after being diagnosed with glaucoma or as a sequel of poor
vision or poor visual field.
2. Patients and Methods
Five hundred and thirty Egyptian patients with a confirmed
diagnosis of primary open angle glaucoma according to
the International Society of Geographical and Epidemiolog-
ical Ophthalmology (ISGEO) classification [8] were initially
approached at the glaucoma clinic of Cairo University Hos-
pital (Kasr Al-Ainy) from June 2012 till January 2015. Of
these, 28 patients declined participating in the study. Sixty-
two patients were willing to participate in the study but were
excluded mainly for being unable to provide clear data as
regards the period of delay and its causes (58 patients), as well
as not wishing to answer the full questionnaire including data
related to their socioeconomic status (4 patients).
Four hundred and forty participants eventually took part
in this study. Informed consent was taken from all patients.
The study adhered to the guidelines of the declaration of
Helsinki [9] and was approved by the institutional ethics
committee.
Cases of open angle glaucoma were diagnosed in accor-
dance with the International Society of Geographical and
Epidemiologic Ophthalmology (ISGEO) classification [8].
Accordingly, primary open angle glaucoma was classified
based on three levels of evidence into three categories. The
first category is based on the presence of structural and
functional evidence. It requires a CDR or CDR asymmetry
≥97.5th percentile (CD 0.7) of the normal population with
a visual field defect that is consistent with glaucoma. The
second category included patients with advanced structural
damage and unproven visual field loss. It included those
subjects in whom visual field testing could not be performed
or yielded unreliable results, with a CDR or CDR asymmetry
≥99.5th percentile for the normal population (CDR 0.85,
CDR asymmetry 0.3).The third category consisted of patients
with an IOP ≥99.5th percentile (CDR 0.85) of the normal
population, whose optic discs could not be assessed due to
media opacities. POAG was diagnosed if a subject fell under
any of the three categories in the presence of an open and
normal appearing angle on gonioscopy [8].
Inclusion criteria were POAG patients, above 20 years of
age, who were on regular antiglaucoma medications or who
underwent argon laser trabeculoplasty (ALT) or glaucoma
surgery and who were coming for follow-up in our glaucoma
clinic.
Exclusion criteria were patients with other types of
glaucoma (chronic angle closure, pigmentary glaucoma,
pseudoexfoliation, or any secondary open angle glaucoma).
Patients who could not remember when they were first
diagnosed with POAG or when they started medications,
patients whowished to keep their data personal, and/or those
with a documented psychiatric condition which interfered
with taking the questionnaire were also excluded from the
study.
The authors met two types of glaucoma patients; type A
patients who had symptoms that were likely caused by glau-
coma (like visual field defects consistent with glaucoma) and
who consequently sought ophthalmological advice and were
eventually diagnosed with POAG and type B patients who
were opportunistically discovered during routine medical
checkup or those who presented to an ophthalmologist with a
complaint that ismostly unrelated to glaucoma (e.g., to renew
their glasses, to treat conjunctivitis, or for LASIK assessment)
and were advised to be investigated for glaucoma.
One-to-one in-depth interview was held with each
patient during one of his/her follow-up visits. Patients were
thoroughly interviewed about the history of their disease.The
patient was asked if he/she can clearly state when was the
very first time that he/she sought ophthalmological advice
(in type A patients) or the first time that he/she was told
there was a suspicion of glaucoma (in type B patients). The
patient was then askedwhen his/her diagnosis was confirmed
for glaucoma, and since when he/she was on antiglaucoma
medications or underwent ALT or glaucoma surgery.
Theperiod between the very first appearance of a problem
(symptoms in type A patients or suspicion of POAG in
type B patients) and the date of initiation of antiglaucoma
therapy (whether medical or interventional) was calculated
in years—or fraction of years—and was recorded as the “total
delay.” Patients in whom the total delay did not exceed one
month (0.08 years) were considered to have zero total delay.
Since typically it takes up to a month for a newly diagnosed
glaucoma patient in Egypt to have the required investigations
done, book a follow-up appointment, and get started on
antiglaucoma medications.
The patient was then further asked about the predomi-
nant reason for this delay. The predominant cause of delay
(the type of delay) was further classified by the authors
as either patient, diagnostic, or treatment delay (Figure 1).
Patient delay was defined as the time between the onset
of a complaint (in type A patients) and the patient’s first
presentation to an ophthalmologist. TypeBpatientswhowere
discovered opportunistically were considered to have zero
patient delay andwere opt to be evaluated only for “diagnostic
and/or treatment delay” because these patients’ delay cannot
be attributed to them as they had no ocular complaint.
Diagnostic delay was defined as the interval between the
first consultation with an ophthalmologist and the confirmed
diagnosis of glaucoma. Treatment delay was defined as the
interval between the confirmed diagnosis of glaucoma and
the actual initiation of therapy whether topical medications,
ALT, or surgery whichever came first.
All questions were asked by the same investigator and
each interview took about twenty minutes. The interviewer
asked the patients in a relaxed atmosphere, posing the
questions in a nonleading, open discussion manner. The
interviewer stressed on the importance of receiving accu-
rate information rather than just getting all his questions
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Figure 1: Conceptual diagram on the definition of delays, adapted from Yimer et al. [7].
answered and encouraged the patient to inform him of not
being able to give an accurate answer rather than speculating.
The patients were asked to bring or show any supportive
documents (like old prescriptions, old field test printouts, or
requests for investigations) with a date on themwhich helped
to further validate the dates that they reported.
To further understand the reasons behind this type of
delay, further questions were asked about the cause which has
led to this type of delay.The exact cause behind a certain type
of delay was enquired about. The patient was also asked if he
had encountered any restrictions on his daily activities, for
example, if he had to resign from or change a certain job or
stop driving or cycling because of his visual disability.
After the “cause of delay”was thoroughly investigated, the
patient was then asked about his education level (classified
by authors into the following: illiterate, finished elementary
education, middle or high school, and having a university
degree or higher), the presence or absence of a family
history of glaucoma, the presence of an associated systemic
disease (diabetes, hypertension, ischemic heart disease, or
others), whether he had enough knowledge about the risk
and possible consequences of glaucoma, and finally whether
the patient is covered by medical insurance or not (whether
partially or totally). The participant’s age, sex, and laterality
of disease were also recorded for all patients. Statistical
correlations were then examined between the extent of total
delay and all these socioeconomic factors.
Data were statistically described in terms of mean ±
standard deviation (±SD), median, range and percentiles,
or frequencies (number of cases) and percentages when
appropriate. Correlation between various variables was done
using Spearman rank correlation equation. A 𝑃 value less
than 0.05 was considered statistically significant. All statis-
tical calculations were done using computer program SPSS
(Statistical Package for the Social Science, SPSS Inc., Chicago,
IL, USA).
3. Results
Our study included 143 (32.5%) females and 297 (67.5%)
males with a mean age of 52.05 ± 8.42 years.
The mean total delay was 2.31 ± 3.51 years, ranging from
zero to 27 years.Themedian total delay was one year with half
the number of patients falling below and the other half falling


















Figure 2: Distribution of total delay in years (y-axis) among number
of cases (x-axis).
The twenty-fifth percentile was found to be at zero years
(i.e., 25% of patients had zero total delay), the 50th percentile
was at one year (50% of patients showed a total delay of 1
year or less), the seventy-fifth percentile was at 3 years with
75% of patients showing a delay of 3 years or less, and the
last 25% of patients showed a total delay between 3 and 27
years. Interquartile range (IQR) ranged from 1 to 36 months.
Figure 2 shows the individual distribution of total delay in
years among our 440 patients.
Upon further analysis of data, we found that, out of
the 330 patients (75%) who exhibited a positive total delay,
“patient delay” accounted for 56 patients (16.96%) “diagnostic
delay” for 142 patients (43.03%), and “treatment delay” for 132
patients (40%).
3.1. Upon Analyzing Causes of “Patient Delay”. 21.05% were
type A patients who had poor vision and/or a visual field
defect which they initially ignored. 78.95 % were type B
patients who were advised to seek an ophthalmologist for
suspicion of glaucoma. Of these, 10.52% had miscellaneous
personal reasons for not promptly seeking specialized eye
care, like being pregnant and preferring to wait for delivery
first, working abroad or repeated business travel, and being
on a waiting list to see a special doctor, and some said they
had personal issues that they did not want to reveal. The
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remaining 68.43% stated that they simply ignored a doctor’s
advice to see a specialized ophthalmologist for suspected
glaucoma because they did not think it was a serious problem.
3.2.TheMainReasons forDiagnosticDelay. Themain reasons
for diagnostic delay were inability to afford the cost of inves-
tigations needed to confirm the diagnosis (36.96%), delay in
performing the needed investigations due to prolonged paper
work with medically insured patients (36.96%), controversial
doctor’s opinions in patients who preferred to take a second
opinion (17.39%), and patients with ocular hypertension
(OHT), suspicious cupping, or visual field defects, who later
progressed into glaucoma and were not timely diagnosed at
the transition into actual glaucoma that required treatment
(8.69%).
3.3.TheMain Reasons for Treatment Delay. Themain reasons
for treatment delay were inability to afford the cost of
medications and other therapy forms (68.3%) and patient
delay in the execution of the prescribed treatment regimen
due to ignorance and/or nonadherence or poor explanation
of the importance of treatment by the treating doctor (31.7%).
Upon correlating the extent of total delay period with the
patients’ age, sex, and other socioeconomic factors we found
the following (Table 1).
3.3.1. Age and Sex of the Patient. A positive correlation was
found between the extent of total delay in years and the age
of the patient (𝑟 = 0.438), which was statistically of high
significance (𝑃 < 0.001). However, no significant correlation
was found (𝑟 = 0.058) between the patient’s sex and the extent
of delay in years (𝑃 = 0.225).
3.3.2. Level of Education and Knowledge about the Disease.
A negative correlation of high statistical significance (𝑃 <
0.001) was found between the level of education of patients
and the total delay in years, with the delay increasing the less
the patient’s education level (𝑟 = −0.366).
Another highly significant (𝑃 < 0.001) negative cor-
relation was found between the patient’s knowledge about
glaucoma as a disease and its possible sequelae and the delay
in years. Again longer delays were met in patients with poor
knowledge about glaucoma (𝑟 = −0.283).
3.3.3. Laterality of Glaucoma and the Presence of Associated
Systemic Disease. No statistically significant correlation (𝑟 =
0.030) was found between the disease being unilateral or
bilateral and the delay in years (𝑃 = 0.533). However, a
statistically highly significant (𝑃 < 0.001) positive correlation
was found between the presence of associated systemic
disease and the extent of delay in years (𝑟 = 0.219).
3.3.4. Family History of Glaucoma and the Presence of Medical
Insurance. A highly significant negative correlation (𝑃 <
0.001) was found between having a positive family history
of glaucoma and the extent of delay in years, with patients
exhibiting shorter delay if they had a positive family history
of glaucoma (𝑟 = −0.305). Another statistically significant



































(𝑃 = 0.010) weak positive correlation (𝑟 = 0.122) was
found between having a medical insurance and the delay
in years with patients having medical insurance exhibiting
longer delay intervals. Table 1 summarizes the correlations
between the total delay in years and demographic as well as
other socioeconomic variables.
Of our 440 interviewed patients, 14 patients (3.18%) had
to quit their job or change it to a less visually demanding
one. Twenty-nine patients have stopped driving cars, buses,
or tricycles (6.59%). Most patients gave positive complaints
about becoming less independent at home, a complaint
which was not considered statistically because of its possible
psychological origin (false sense of insecurity).
4. Discussion
The mean total delay in this study was 2.31 ± 3.51 years.
The median total delay was one year, and interquartile range
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(IQR) was 1–36 months. The main type of delay in our study
was diagnostic delay, where it took patients longer than usual
to get an accurate and confirmed diagnosis of glaucoma.This
has an impact on the prognosis of disease. Our results which
showed a positive delay in 75% of our cases were similar
to those reported in a study done in Iran on 258 newly
diagnosed glaucoma patients [5]. However, this study focused
on low socioeconomic status effect on the severity of disease
at initial presentation andnot on the types and causes of delay.
Socioeconomic factors seem to have a direct impact on the
prognosis of chronic diseases, including glaucoma [10–14].
In our study, a main cause of both diagnostic and
treatment delay in POAG patients was financial incapacity,
either to perform the investigations needed (36.96%) or to
buy the required medication (68.3%). This also agrees with
the previous studies.
Our main type of delay was diagnostic delay, being
responsible for 43.03% of patients who suffered delay. We
presume that the lack of medical insurance in most patients
would account for this delay in diagnosis, as the cost of initial
investigations is high. However, we found that 36.96% of our
patients who had diagnostic delay complained of prolonged
paper work which delayed the course of diagnosis despite the
fact that they were medically insured. It seems that having
medical insurance may contribute to delay by the prolonged
paper work in our healthcare system.
Developing countries often have highly heterogeneous
healthcare delivery system, with both public and private
sector healthcare providers. Patients tend to move from one
provider to another before they are finally properly diagnosed
by a specialist and given proper treatment [6, 15, 16]. This
was also true with our patients, who spent some time looking
for the right eye specialist and/or whose diagnosis was
sometimes delayed due to controversial doctors’ opinions
from different healthcare providers.The patient finally settles
with the specialist whom he follows up with but some time
may elapse until this is attained.
Delay in the diagnosis and treatment of POAG seemed to
affect our patients’ lifestyle as well, with 9.77% of our patients
having had to either resign from or change a job or stop
driving vehicles as a result of their visual impairment.
Upon studying the correlations between the extent of total
delay in years and patient’s socioeconomic factors, we found
that higher patient education level, a positive family history
of glaucoma, and knowledge about the nature of glaucoma
were all associated with shorter periods of delay, as opposed
to increasing patient’s age, the presence of associated disease,
and the presence of medical insurance which seemed to be
associated with longer delay periods. These findings agree
withwhat other studies found that patient awareness and level
of education are important factors for prompt diagnosis and
management of disease [17]. A higher male-to-female ratio
was noted in our sample population.Whether that represents
a true gender difference in disease distribution or is just due
to males having easier access to healthcare providers due to
cultural factors needs to be further investigated.
However, there are limitations to our study. POAG, unlike
other diseases like tuberculosis or cancer, is largely initially
asymptomatic inevitably leads to some sort of “natural delay”
so long as the patient is not yet discovered. Besides, being a
questionnaire based study, there is a chance of some recall
bias among patients. However, we tried to minimize that
by excluding any patients who did not give clear-cut dates
about their delay period (at least with respect to number of
years and months). We believe that the results we got can
still contribute to evaluating the magnitude of the problem
of delay in POAG diagnosis and treatment in our society.
Since the high costs of investigations and treatment
were found to be major obstacles leading to diagnostic
and treatment delay in our study, the authors recommend
that more money should be spent subsidizing treatment of
glaucoma patients. More efforts should be done to provide
adequate medical insurance minimizing the steps involving
paper work so the patients can be promptly put on track
for glaucoma diagnosis and treatment. Glaucoma awareness
programs should havemore weight in themedia and in clubs,
youth organizations, and universities. Explanatory posters
should be hanged and seminars held to educate the general
population about glaucoma and its long term effects as this
shall decrease possible future patient delay.
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